Literature DB >> 35451652

Downregulated long intergenic non-coding RNA 00,174 represses malignant biological behaviors of lung cancer cells by regulating microRNA-584-3p/ribosomal protein S24 axis.

Shaobin Wang1, Lixia Xia2, Bin Zhang2, Hao Zhang2, Fen Lan3.   

Abstract

The detailed regulatory mechanism of LINC00174 in lung cancer (LC) development remains largely unknown. This research was designed to probe into the impacts of LINC00174 in LC cells through modulating the microRNA (miR)-584-3p/ribosomal protein S24 (RPS24) axis. LINC00174, miR-584-3p, and RPS24 expression levels in LC cells and tissues were examined. The constructs altering LINC00174, miR-584-3p, or RPS24 expression were transfected into LC cells to examine the malignant phenotypes of LC cells. The relations among LINC00174, miR-584-3p, and RPS24 were validated. LINC00174 and RPS24 were high-expressed while miR-584-3p was low-expressed in LC. Downregulated LINC00174 or RPS24 or upregulated miR-584-3p inhibited the malignant biological behaviors of LC cells. The silenced miR-584-3p could reverse the repressive effects of reduced LINC00174 on the development of LC cells; while RPS24 overexpression inverted the repressive effects of miR-584-3p elevation on LC cells. Mechanically, LINC00174 bound to miR-584-3p that targeted RPS24. Repressed LINC00174 can relieve the malignant phenotypes of LC cells via modulating the miR-584-3p/RPS24 axis.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; Long intergenic non-coding RNA 00,174; Lung cancer; MicroRNA-584-3p; Migration; Ribosomal protein S24

Mesh:

Substances:

Year:  2022        PMID: 35451652     DOI: 10.1007/s10142-022-00855-7

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.674


  2 in total

1.  miR‑584‑5p regulates migration and invasion in non‑small cell lung cancer cell lines through regulation of MMP‑14.

Authors:  Tianmin Guo; Chenzhao Zheng; Zhigang Wang; Xifu Zheng
Journal:  Mol Med Rep       Date:  2019-01-03       Impact factor: 2.952

Review 2.  Heterogeneity in Lung Cancer.

Authors:  Vitor Manuel Leitão de Sousa; Lina Carvalho
Journal:  Pathobiology       Date:  2018-04-10       Impact factor: 4.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.